Clinical Trial: T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07447531) titled 'T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas' on Feb. 24.

Brief Summary: This clinical trial studies whether T2 star (T2*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.

Study Start Date: Oct. 03, 2025

Study Type: INTERVENTIONAL

Condition: Malignant Glioma

Intervention: PROCEDURE: T2 (Observed)-Weighted Imaging

Undergo T2* MRI

PROCEDURE: Biospecimen Collection

Undergo blood sample collection

PROCEDURE: Magnetic R...